0000899243-16-033607.txt : 20161115
0000899243-16-033607.hdr.sgml : 20161115
20161115192257
ACCESSION NUMBER: 0000899243-16-033607
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160812
FILED AS OF DATE: 20161115
DATE AS OF CHANGE: 20161115
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sorrento Therapeutics, Inc.
CENTRAL INDEX KEY: 0000850261
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 330344842
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9380 JUDICIAL DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-210-3700
MAIL ADDRESS:
STREET 1: 9380 JUDICIAL DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: QUIKBYTE SOFTWARE INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZELDIS JEROME B
CENTRAL INDEX KEY: 0001433982
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36150
FILM NUMBER: 162001075
MAIL ADDRESS:
STREET 1: 8767 E. VIA DE VENTURA, SUITE 190
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85258
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-08-12
0
0000850261
Sorrento Therapeutics, Inc.
SRNE
0001433982
ZELDIS JEROME B
C/O SORRENTO THERAPEUTICS, INC.
9380 JUDICIAL DRIVE
SAN DIEGO
CA
92121
0
1
0
0
See Remarks
Stock Options
6.52
2016-08-12
4
A
0
200000
0.00
A
2026-08-12
Common Stock
200000
200000
D
1/4 of the original number of shares subject to the option shall vest on August 12, 2017 and 1/48 of the original number of shares subject to the option shall vest following each one month period of service after August 12, 2017, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
Chief Medical Officer and President of Clinical Development
/s/ Jerome Zeldis
2016-11-15